TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15649828

Group type: EXPERIMENTAL
Intervention: Total glycoalkaloid (TGA) doses of 0.30 mg/kg BW
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Total glycoalkaloid (TGA) doses of 0.50 mg/kg BW
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Total glycoalkaloid (TGA) doses of 0.70 mg/kg BW
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Mashed potatoes with TGA doses of 0.95 mg/kg BW
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Mashed potatoes with TGA doses of 1.10 mg/kg BW
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Mashed potatoes with TGA doses of 1.25 mg/kg BW
Number of subjects: 6
Study: 12678198

Group type: EXPERIMENTAL
Intervention: Trimetazidine (TMZ) plus dexrazoxane (DEX) (60 mg, daily dose)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Trimetazidine (TMZ) only
Number of subjects: 61

Group type: COMPARATOR
Intervention: Dexrazoxane (DEX) only
Number of subjects: 61
Study: 10526899

Group type: EXPERIMENTAL
Intervention: Passive smoke exposure (carbon monoxide concentration between 20 and 40 p.p.m.)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Vehicle (room air)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Acetylcholine (ACh) infusion
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (SNP) infusion
Number of subjects: 12
Study: 7721406

Group type: EXPERIMENTAL
Intervention: Enalapril (20 mg BID)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Nifedipine (60 mg OD)
Number of subjects: 6
Study: 2259927

Group type: EXPERIMENTAL
Intervention: Oral tamoxifen citrate 10 mg twice daily
Number of subjects: 156

Group type: COMPARATOR
Intervention: Oral megestrol acetate 40 mg four times a day
Number of subjects: 156
Study: 7402688

Group type: EXPERIMENTAL
Intervention: Histamine infusion at 0.16, 0.33, and 0.66 microgram/kg/min
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Histamine infusion
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: H1 blocking agent (mepyramine)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: H2 blocker (cimetidine)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 6389385

Group type: EXPERIMENTAL
Intervention: Alclometasone dipropionate cream 0.05%
Number of subjects: 43

Group type: COMPARATOR
Intervention: Clobetasone butyrate cream 0.05%
Number of subjects: 43
Study: 31305275

Group type: EXPERIMENTAL
Intervention: Cytoreductive nephrectomy followed by sunitinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sunitinib alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Initial sunitinib followed by deferred cytoreductive nephrectomy
Number of subjects: 0
Study: 29453980

Group type: EXPERIMENTAL
Intervention: RFVE with CR
Number of subjects: 136

Group type: COMPARATOR
Intervention: CR
Number of subjects: 136
Study: 27015295

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 210

Group type: COMPARATOR
Intervention: Conventional combination treatment (sulfasalazine plus hydroxychloroquine)
Number of subjects: 210
Study: 25062129

Group type: EXPERIMENTAL
Intervention: balafilcon A (silicone hydrogel)
Number of subjects: 108

Group type: COMPARATOR
Intervention: etafilcon A (hydrogel)
Number of subjects: 108
Study: 22378918

Group type: EXPERIMENTAL
Intervention: Lithium carbonate (target blood level 0.4‐0.8 mEq/l)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Lithium carbonate and Placebo
Number of subjects: 133
Study: 20631694

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (50 mg intravenously)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fludrocortisone (50 microg orally)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hydrocortisone and Fludrocortisone (combined)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 17016794

Group type: EXPERIMENTAL
Intervention: Tolterodine treatment for OAB over 12 weeks
Number of subjects: 1211
Study: 15661432

Group type: EXPERIMENTAL
Intervention: Granisetron (5‐HT3‐antagonist)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Diclofenac‐sodium (PGE2‐antagonist)
Number of subjects: 20
Study: 12182264

Group type: COMPARATOR
Intervention: Health information intervention (I only)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Information plus skills-based safer sex training (I + B)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Information plus skills-based safer sex training and risk-sensitization manipulation (I + M + B)
Number of subjects: 161
Study: 10213211

Group type: EXPERIMENTAL
Intervention: Low dose paclitaxel (135 mg/m2, 24-h i.v. infusion)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: High dose paclitaxel (250 mg/m2, 24-h i.v. infusion)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Combined analysis of paclitaxel concentrations from both treatment arms
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Paclitaxel Css,avg
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Worst grade of leukopenia
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Combined effect of demographic and stratification variables
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Lower disease stage (stage IIIb)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Lower ECOG performance status (= 0)
Number of subjects: 146
Study: 8547682

Group type: EXPERIMENTAL
Intervention: Infection control measures implemented at Facility A (increased surveillance, handwashing reinforcement, isolation of symptomatic residents, and relief of symptomatic staff from duties).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: More stringent infection control measures implemented at Facility B (all measures from Facility A plus additional restrictions on staff movement, closure of affected units to new admissions, enteric precautions for ill residents, restriction of residents to their own units, and education about gastroenteritis).
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison of attack rates between Facility A and Facility B.
Number of subjects: 0
Study: 2198297

Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 655675

Group type: EXPERIMENTAL
Intervention: Long term 5-FU administered after postoperative irradiations for gastric cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Levamisole as adjuvant treatment for colon cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemotherapy in advanced colon cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy for rectal cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemotherapy as a preoperative irradiation sensitizer in rectal cancer
Number of subjects: 0
Study: 31830976

Group type: EXPERIMENTAL
Intervention: Completion proctectomy and IPAA without defunctioning ileostomy (experimental group)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Completion proctectomy and IPAA with defunctioning ileostomy (control group)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Both strategies (with and without ileostomy)
Number of subjects: 194
Study: 28222422

Group type: COMPARATOR
Intervention: Exercise-only control (E)
Number of subjects: 454

Group type: EXPERIMENTAL
Intervention: Diet-induced weight loss (D)
Number of subjects: 454

Group type: EXPERIMENTAL
Intervention: Diet-induced weight loss + exercise (D+E)
Number of subjects: 454
Study: 25634107

Group type: EXPERIMENTAL
Intervention: Visual biofeedback from the display monitor, in the form of symbolic feet as the subject took a step
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Auditory biofeedback associated display, using a metronome at 115% of the individual's preferred cadence
Number of subjects: 30

Group type: COMPARATOR
Intervention: Partial body weight supported (PBWS) treadmill training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (only PBWS treadmill training)
Number of subjects: 30
Study: 23559124

Group type: EXPERIMENTAL
Intervention: Salbutamol 200 µg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Salbutamol 800 µg
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 21184876

Group type: EXPERIMENTAL
Intervention: Water method
Number of subjects: 100

Group type: COMPARATOR
Intervention: Air method
Number of subjects: 100
Study: 19522395

Group type: EXPERIMENTAL
Intervention: Xiaoyusan plaster and Daoyin
Number of subjects: 63

Group type: COMPARATOR
Intervention: Votalin Sustained Release Tablets
Number of subjects: 63
Study: 18091987

Group type: EXPERIMENTAL
Intervention: 1.0% C31G (SAVVY) gel
Number of subjects: 2142

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 2142
Study: 15570357

Group type: EXPERIMENTAL
Intervention: Eptifibatide
Number of subjects: 2064

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2064
Study: 11064611

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 40
Study: 8738073

Group type: EXPERIMENTAL
Intervention: i.v. meperidine 100 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: i.v. tramadol 100 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: saline (control)
Number of subjects: 48
Study: 1493086

Group type: EXPERIMENTAL
Intervention: 1 mg glucagon from pancreatic extraction intramuscularly
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1 mg genetically engineered glucagon intramuscularly
Number of subjects: 10

Group type: COMPARATOR
Intervention: 25 g glucose intravenously
Number of subjects: 10
Study: 2859712

Group type: EXPERIMENTAL
Intervention: Astemizole, 10 mg on rising
Number of subjects: 85

Group type: COMPARATOR
Intervention: Terfenadine, 60 mg on rising and in the evening
Number of subjects: 85
Study: 30479519

Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS) during Roller Massage (RM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rolling without TENS application (Control)
Number of subjects: 0
Study: 28697860

Group type: EXPERIMENTAL
Intervention: Multimodal nutritional management (MNM)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Traditional protocol
Number of subjects: 162
Study: 26710337

Group type: EXPERIMENTAL
Intervention: Pharmacogenetic warfarin dosing
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard pharmacodynamic method (Control)
Number of subjects: 200
Study: 22056474

Group type: EXPERIMENTAL
Intervention: Lipid-lowering medication
Number of subjects: 2263

Group type: EXPERIMENTAL
Intervention: Lifestyle advice (weight reduction, healthy diet, physical activity, no-smoking)
Number of subjects: 2263
Study: 21047696

Group type: EXPERIMENTAL
Intervention: New prognostic score developed from training dataset
Number of subjects: 687

Group type: EXPERIMENTAL
Intervention: New prognostic score
Number of subjects: 687

Group type: COMPARATOR
Intervention: BCLC and CLIP scores
Number of subjects: 687

Group type: EXPERIMENTAL
Intervention: CLIP + PS
Number of subjects: 687
Study: 18813411

Group type: EXPERIMENTAL
Intervention: Zinc sulfate 50 mg daily for 60 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo for 60 days
Number of subjects: 60
Study: 16730766

Group type: EXPERIMENTAL
Intervention: Pastorex® latex agglutination test
Number of subjects: 484
Study: 14690101

Group type: EXPERIMENTAL
Intervention: Epidural levobupivacaine 0.5% 15 mL
Number of subjects: 65

Group type: COMPARATOR
Intervention: Epidural ropivacaine 0.75% 15 mL
Number of subjects: 65
Study: 10733052

Group type: EXPERIMENTAL
Intervention: Metrifonate (60/80 mg)
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Metrifonate (40/50 mg)
Number of subjects: 603

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 603
Study: 8604962

Group type: EXPERIMENTAL
Intervention: Active antihypertensive drug therapy
Number of subjects: 4367

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4367
Study: 1356466

Group type: COMPARATOR
Intervention: Tap water
Number of subjects: 705

Group type: EXPERIMENTAL
Intervention: Sterile saline
Number of subjects: 705
Study: 2414783

Group type: EXPERIMENTAL
Intervention: Iloprost (25 micrograms)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Iloprost (75 micrograms)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control skin area
Number of subjects: 8
Study: 30691013

Group type: EXPERIMENTAL
Intervention: Telephone coaching sessions (n = 12 calls) with SMS prompting (n = 48 SMSs)
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Telephone coaching sessions (n = 12 calls) without SMS prompting
Number of subjects: 288

Group type: COMPARATOR
Intervention: Single written PA recommendation (minimal intervention group)
Number of subjects: 288
Study: 29280723

Group type: EXPERIMENTAL
Intervention: Occupational therapy with adjustment of challenge-skill balance
Number of subjects: 56

Group type: COMPARATOR
Intervention: Occupational therapy without adjustment of challenge-skill balance
Number of subjects: 56
Study: 27702796

Group type: EXPERIMENTAL
Intervention: HPV and cytology co-testing (intervention)
Number of subjects: 43339

Group type: COMPARATOR
Intervention: Cytology testing only (control)
Number of subjects: 43339

Group type: EXPERIMENTAL
Intervention: HPV negative women aged at least 40 years
Number of subjects: 43339

Group type: EXPERIMENTAL
Intervention: HPV positive women with negative cytology, HPV 16/18 genotyping, and/or repeat cytology
Number of subjects: 43339
Study: 25050368

Group type: EXPERIMENTAL
Intervention: Epithelium-on CXL
Number of subjects: 20

Group type: COMPARATOR
Intervention: Epithelium-off CXL
Number of subjects: 20
Study: 21962296

Group type: EXPERIMENTAL
Intervention: Early mobilisation (first day post surgery)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control (bed rest with elevation until day 2 post surgery)
Number of subjects: 104
Study: 19875994

Group type: EXPERIMENTAL
Intervention: Bioelectrical impedance analysis (BIA) using TANITA TBF-300
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: New ethnic-specific prediction equations generated from the entire sample
Number of subjects: 382

Group type: COMPARATOR
Intervention: Deuterium (D(2)O) as the reference method
Number of subjects: 382
Study: 18757050

Group type: EXPERIMENTAL
Intervention: Prednisolone for 10 days
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo for 10 days
Number of subjects: 123
Study: 15856076

Group type: EXPERIMENTAL
Intervention: metoclopramide (up to 40 mg/day)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: naproxen (up to 1000 mg/day)
Number of subjects: 105

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 105
Study: 14716965

Group type: EXPERIMENTAL
Intervention: Fluticasone/salmeterol combination 250/50 micrograms one inhalation twice daily
Number of subjects: 246

Group type: COMPARATOR
Intervention: CFC beclomethasone dipropionate 250 micrograms two puffs twice daily plus montelukast 10 mg in the evening
Number of subjects: 246
Study: 11010699

Group type: EXPERIMENTAL
Intervention: Small group educational intervention for urinary incontinence
Number of subjects: 108

Group type: COMPARATOR
Intervention: Wait control condition
Number of subjects: 108
Study: 8195464

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 225

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 225
Study: 3296225

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 31923729

Group type: EXPERIMENTAL
Intervention: T-DM1
Number of subjects: 1961
Study: 29679336

Group type: EXPERIMENTAL
Intervention: MGB-OAGB
Number of subjects: 201

Group type: COMPARATOR
Intervention: LSG
Number of subjects: 201
Study: 27634081

Group type: EXPERIMENTAL
Intervention: Hamstrings stretching alone
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Hamstrings stretching combined with ischemic compression of the masseter muscle
Number of subjects: 42
Study: 26350445

Group type: EXPERIMENTAL
Intervention: School-based preventive intervention targeting moral disengagement, empathy, and social cognitive predictors of cyberbullying
Number of subjects: 355

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 355
Study: 22673870

Group type: EXPERIMENTAL
Intervention: Inpatient rehabilitation measures (IG)
Number of subjects: 477

Group type: COMPARATOR
Intervention: Waiting group (WG)
Number of subjects: 477

Group type: COMPARATOR
Intervention: Rejected group (AG)
Number of subjects: 477
Study: 21292553

Group type: EXPERIMENTAL
Intervention: Motivational school-based intervention (4 sessions of 50 minutes each)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Motivational school-based intervention
Number of subjects: 104
Study: 19517673

Group type: EXPERIMENTAL
Intervention: Combined cervical plexus block using Winnie technique
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Combined cervical plexus block using Moore technique
Number of subjects: 75

Group type: COMPARATOR
Intervention: Both techniques (Winnie and Moore)
Number of subjects: 75
Study: 17289172

Group type: EXPERIMENTAL
Intervention: Epirubicin and paclitaxel (Group A)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Mitoxantrone and docetaxel (Group B)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control Group C (female patients with heart failure)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control Group D (healthy women)
Number of subjects: 40
Study: 15537846

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Terlipressin or somatostatin combined with endoscopic ligation or sclerotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-selective beta-blockers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Band ligation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novel therapies targeting intrahepatic resistance
Number of subjects: 0
Study: 11345477

Group type: EXPERIMENTAL
Intervention: Alcoholic beverage condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonalcoholic condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Situational cue (low inhibition in Study 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Situational cue (high instigation in Study 2)
Number of subjects: 0
Study: 9046455

Group type: EXPERIMENTAL
Intervention: Spinal manipulation (six sessions of high-velocity, low-amplitude manipulation to the cervical and upper thoracic regions during a 3-4 week period)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Stretching exercises (two unsupervised sessions daily over the same time period)
Number of subjects: 20
Study: 7702382

Group type: EXPERIMENTAL
Intervention: Bag in bottle system
Number of subjects: 20
Study: 2571497

Group type: EXPERIMENTAL
Intervention: alpha-methylparatyrosine
Number of subjects: 24

Group type: COMPARATOR
Intervention: methysergide
Number of subjects: 24
Study: 905580

Group type: EXPERIMENTAL
Intervention: 20 mg PGE2 vaginal suppositories
Number of subjects: 48

Group type: COMPARATOR
Intervention: Oxytocin induction (with or without estrogen pre‐treatment)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 48
Study: 31881392

Group type: EXPERIMENTAL
Intervention: Cenicriviroc (CVC) 150 mg orally once daily
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2000
Study: 30844878

Group type: EXPERIMENTAL
Intervention: BUP-XR 300/300 mg
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: BUP-XR 300/100 mg
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: BUP-XR
Number of subjects: 487

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 487
Study: 28203010

Group type: EXPERIMENTAL
Intervention: Three-dimensional printing custom trays using FSD system
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional custom trays fabricated manually
Number of subjects: 20
Study: 25323784

Group type: EXPERIMENTAL
Intervention: Communities That Care (CTC)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control communities
Number of subjects: 12
Study: 23109222

Group type: EXPERIMENTAL
Intervention: 40,000 IU cholecalciferol per week
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: 20,000 IU cholecalciferol per week
Number of subjects: 318

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 318
Study: 21308781

Group type: COMPARATOR
Intervention: Risperidone (20 patients, 3 mg daily)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Aripiprazole (21 patients, 15 mg daily)
Number of subjects: 41
Study: 19363695

Group type: EXPERIMENTAL
Intervention: Carbohydrate beverage (200 ml containing 12.5% maltodextrin) given 2 hours before operation
Number of subjects: 21

Group type: COMPARATOR
Intervention: 8 hours fasting (control group)
Number of subjects: 21
Study: 16222548

Group type: EXPERIMENTAL
Intervention: Levamisole (2.5 mg/kg on alternate days for 1 year)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control (low-dose prednisolone <0.5 mg/kg on alternate days for 1 year)
Number of subjects: 56
Study: 12734506

Group type: EXPERIMENTAL
Intervention: Tazarotene cream 0.1%
Number of subjects: 1303

Group type: EXPERIMENTAL
Intervention: Tazarotene cream 0.05%
Number of subjects: 1303

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 1303
Study: 10679495

Group type: COMPARATOR
Intervention: Weight loss intervention
Number of subjects: 181

Group type: COMPARATOR
Intervention: Dietary sodium reduction intervention
Number of subjects: 181
Study: 9301382

Group type: EXPERIMENTAL
Intervention: Captopril 0.8‐0.9 mg kg‐1 orally, 45 min before induction of anaesthesia
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no preoperative medication)
Number of subjects: 24
Study: 8130356

Group type: EXPERIMENTAL
Intervention: Steroid-free immunosuppression (complete avoidance of steroids or withdrawal of steroids less than 3 months after transplantation)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Steroid therapy (control group)
Number of subjects: 7
Study: 3481333

Group type: EXPERIMENTAL
Intervention: Ofloxacin 200mg once daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: Norfloxacin 400mg twice daily
Number of subjects: 30
Study: 31935146

Group type: EXPERIMENTAL
Intervention: 308-nm excimer laser (three times weekly for 8 weeks)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Topical placebo
Number of subjects: 26